M.S. Quezada

fastp: an ultra-fast all-in-one FASTQ preprocessor

Procedure‐related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta‐analysis

Course of the sFlt-1/PlGF ratio in fetal growth restriction and correlation with biometric measurements, feto-maternal Doppler parameters and time to delivery

Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach

Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes

DNA Sequencing versus Standard Prenatal Aneuploidy Screening

Replacing the Combined Test by Cell-Free DNA Testing in Screening for Trisomies 21, 18 and 13: Impact on the Diagnosis of Other Chromosomal Abnormalities

Assessment of Fetal Sex Chromosome Aneuploidy Using Directed Cell-Free DNA Analysis

Cell-free DNA Analysis for Noninvasive Examination of Trisomy

Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis

Liquid biopsies come of age: towards implementation of circulating tumour DNA

Single-Nucleotide Polymorphism–Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk Cohort

Exploring Preterm Birth as a Polymicrobial Disease: An Overview of the Uterine Microbiome

Down syndrome

22q11.2 deletion syndrome

Down Syndrome

Fetal therapy for Down syndrome: an ethical exploration

Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?

Clinical experience with single‐nucleotide polymorphism‐based non‐invasive prenatal screening for 22q11.2 deletion syndrome

The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota

First‐trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell‐free DNA testing

Circulating cell free DNA testing: are some test failures informative?

Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies

Prenatal Detection of Fetal Triploidy from Cell-Free DNA Testing in Maternal Blood

Longitudinal change of sFlt‐1/PlGF ratio in singleton pregnancy with early‐onset fetal growth restriction

Cell-Free DNA Analysis for Trisomy Risk Assessment in First-Trimester Twin Pregnancies

Screening for trisomies 21, 18 and 13 by cell‐free DNA analysis of maternal blood at 10–11 weeks' gestation and the combined test at 11–13 weeks

Analysis of Cell-Free DNA in Maternal Blood in Screening for Aneuploidies: Meta-Analysis

Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis

sFlt‐1/PlGF ratio and timing of delivery in early‐onset fetal growth restriction with antegrade umbilical artery flow

Implementation of maternal blood cell‐free DNA testing in early screening for aneuploidies